Research in cancer immunotherapy for gynecologic malignancies is rapidly advancing. Clinical trials are investigating new combinations of immunotherapy with other treatment modalities, such as chemotherapy and targeted therapy. Studies are also focusing on biomarkers that predict response to treatment, aiming to refine patient selection and improve outcomes.
